Fundraising FoxSixty Degree Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
NextPoint is a precision therapeutics company developing cancer treatments targeting the B7-H7/HHLA2 axis, including a T-cell engager, an antibody-drug conjugate with proprietary linker technology, and a multi-functional checkpoint inhibitor.
BiotechHealthtechAustin, US
Gordon Freeman(Scientific Founder)XingXing Zang(Scientific Founder)inIvan Cheung(Chief Executive Officer)inLeena Gandhi(Chief Medical Officer)inTatiana Novobrantseva(Chief Scientific Officer)inAxel Hoos(Director)
Co-investorsCatalio Capital Management, LPMPM BioImpactSanofi VenturesCatalio Capital ManagementInvusLeaps by Bayer
Starcloud is a deep-tech company building large-scale data center infrastructure designed to operate in space.
Advanced ManufacturingAI & Machine LearningClimate TechCloud ComputingData & InfrastructureDeep TechSemiconductorsSpace TechRedmond, US
Philip Johnston(CEO)inEzra Feilden(CTO)inAdi Oltean(Founder)inPaul Adrian Oltean(Executive Officer, Director)Philip Johnston Ezra Feilden(Founder)
BoardMorgan Beller(Director)in
Co-investorsAb Capital Holding BVAmbush CapitalCisco InvestmentsDnx VenturesDragon CapitalFUSE+60 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.